Markus Zabransky
Markus Zabransky publishes mostly in Endocrinology, Diabetes and Metabolism, Pediatrics, Perinatology and Child Health and Molecular Biology, on topics such as Growth Hormone and Insulin-like Growth Factors, Pituitary Gland Disorders and Treatments and Biosimilars and Bioanalytical Methods.
- World rank
- #6,338,959 of 7,710,434 ranked researchers
- Rank in Germany
- #320,815 of 364,343
- Works
- 46
- Citations
- 363
- Citations per work
- 7.9
What does Markus Zabransky research?
Markus Zabransky's work is mostly in Medicine (46%), Biochemistry, Genetics and Molecular Biology (7%), Economics, Econometrics and Finance (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2145.7%
- Medicine2145.7%
- Everything else1736.8%
- Life Sciences511.4%
- Social Sciences36.1%
- 1Endocrinology, Diabetes and Metabolism32% of their works
- 2Pediatrics, Perinatology and Child Health9% of their works
- 3Molecular Biology7% of their works
- 4Economics and Econometrics6% of their works
- 5Physiology4% of their works
- 6Immunology4% of their works
Research topics
- Growth Hormone and Insulin-like Growth Factors
- Pituitary Gland Disorders and Treatments
- Biosimilars and Bioanalytical Methods
- Birth, Development, and Health
- Health Systems, Economic Evaluations, Quality of Life
- Biotin and Related Studies
- Genetic Syndromes and Imprinting
- Sexual Differentiation and Disorders
Which keywords describe Markus Zabransky's research?
The keywords of their largest research topics: Growth Hormone, IGF-1, Insulin-like Growth Factors, Cushing's Syndrome, Pituitary Adenomas, Biosimilars, Cost-effectiveness Analysis and Early-Life Conditions.
- Proximity Labeling
- Genomic Imprinting
- Biotin
- Immunogenicity
- Early-Life Conditions
- Biosimilars
- Cushing's Syndrome
- IGF-1
- Growth Hormone
- Insulin-like Growth Factors
- Pituitary Adenomas
- Cost-effectiveness Analysis
- Fetal Programming
- Quality of Life
- Congenital Adrenal Hyperplasia
- Parental Influence
- Steroid 21-Hydroxylase Deficiency
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Growth Hormone332 topics
- IGF-1241 topic
- Insulin-like Growth Factors241 topic
- Cushing's Syndrome91 topic
- Pituitary Adenomas91 topic
- Biosimilars41 topic
- Cost-effectiveness Analysis41 topic
- Early-Life Conditions41 topic
- Fetal Programming41 topic
- Immunogenicity41 topic
- Quality of Life41 topic
- Biotin31 topic
- Congenital Adrenal Hyperplasia31 topic
- Genomic Imprinting31 topic
- Parental Influence31 topic
- Proximity Labeling31 topic
- Steroid 21-Hydroxylase Deficiency31 topic
Where does Markus Zabransky work?
Markus Zabransky's main affiliation in the publication record is Hexal (Germany), Germany.
How many publications and citations does Markus Zabransky have?
OpenAlex counts 46 works and 363 citations for Markus Zabransky, an h-index of 12, ranking #6,338,959 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Markus Zabransky. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.